Molina Healthcare Inc. (NYSE:MOH) – Stock analysts at Leerink Swann lowered their FY2017 earnings per share (EPS) estimates for Molina Healthcare in a research note issued to investors on Wednesday. Leerink Swann analyst A. Gupte now anticipates that the brokerage will post earnings per share of $4.00 for the year, down from their previous estimate of $4.37. Leerink Swann currently has a “Buy” rating on the stock. Leerink Swann also issued estimates for Molina Healthcare’s FY2018 earnings at $5.09 EPS and FY2019 earnings at $6.24 EPS.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Thursday, October 27th. The company reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.09. The firm earned $4.50 billion during the quarter, compared to the consensus estimate of $4.37 billion. Molina Healthcare had a return on equity of 9.38% and a net margin of 0.76%. The firm’s revenue was up 24.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.89 EPS.

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Several other brokerages also recently weighed in on MOH. Zacks Investment Research downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, October 3rd. Cantor Fitzgerald reiterated a “hold” rating and issued a $55.00 price objective on shares of Molina Healthcare in a research report on Friday, July 29th. Jefferies Group raised their price objective on Molina Healthcare from $63.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, September 13th. Goldman Sachs Group Inc. upgraded Molina Healthcare from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $51.00 to $58.00 in a research report on Monday, September 19th. Finally, Credit Suisse Group AG downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $63.00 to $47.00 in a research report on Friday. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $61.70.

Shares of Molina Healthcare (NYSE:MOH) traded down 5.66% on Thursday, reaching $47.53. The company had a trading volume of 4,144,822 shares. Molina Healthcare has a 12 month low of $44.50 and a 12 month high of $67.87. The firm has a market capitalization of $2.70 billion, a PE ratio of 20.79 and a beta of 1.19. The company’s 50-day moving average is $56.40 and its 200 day moving average is $53.62.

In related news, Director Garrey Carruthers sold 1,600 shares of the firm’s stock in a transaction on Tuesday, September 13th. The stock was sold at an average price of $55.46, for a total transaction of $88,736.00. Following the completion of the sale, the director now directly owns 9,508 shares of the company’s stock, valued at approximately $527,313.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Terry Bayer sold 7,825 shares of the firm’s stock in a transaction on Monday, October 24th. The shares were sold at an average price of $60.00, for a total value of $469,500.00. The disclosure for this sale can be found here. Corporate insiders own 6.89% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Epoch Investment Partners Inc. boosted its stake in Molina Healthcare by 26.6% in the third quarter. Epoch Investment Partners Inc. now owns 770,976 shares of the company’s stock worth $44,963,000 after buying an additional 161,767 shares in the last quarter. Pacer Advisors Inc. boosted its stake in Molina Healthcare by 4.2% in the third quarter. Pacer Advisors Inc. now owns 7,780 shares of the company’s stock worth $453,000 after buying an additional 312 shares in the last quarter. Bellevue Group AG acquired a new stake in Molina Healthcare during the third quarter worth $962,000. Principal Financial Group Inc. boosted its stake in Molina Healthcare by 8.0% in the third quarter. Principal Financial Group Inc. now owns 170,398 shares of the company’s stock worth $9,937,000 after buying an additional 12,629 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Molina Healthcare by 1.1% in the third quarter. Northern Trust Corp now owns 661,040 shares of the company’s stock worth $38,552,000 after buying an additional 7,466 shares in the last quarter. 88.10% of the stock is owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.

5 Day Chart for NYSE:MOH

Receive News & Stock Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related stocks with our FREE daily email newsletter.